EQ Equillium Forecast, Technical & Fundamental Analysis

a developer of products for severe immune-inflammatory disorders

Industry Biotechnology

Get AI intraday signals

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For EQ
(Try 14 days for Free)

View a ticker or compare two or three

Compare

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For EQ
(Try 14 days for Free)

Ad is loading...

A.I. Advisor

published Earnings

EQ is expected to report earnings to fall ∞% to -28 cents per share on March 26

Q4'24

Est.

$-0.28

Q3'24

Missed

by $0.02

Q2'24

Beat

by $0.16

Q1'24

Beat

by $0.09

Q4'23

Beat

by $0.10

The last earnings report on November 13 showed earnings per share of 0 cents, missing the estimate of 1 cents. With 151.73K shares outstanding, the current market capitalization sits at 22.43M.

A.I. Advisor

published General Information

General Information

a developer of products for severe immune-inflammatory disorders

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

2223 Avenida De La Playa

Phone

+1 858 240-1200

Employees

Web

https://www.equilliumbio.com

Interesting Tickers

STOCK / NAME	Price $	Chg $	Chg %
		1 Day
GME	31.26	1.82	+6.18%
GameStop Corp
TSLA	479.86	16.84	+3.64%
Tesla
AAPL	253.48	2.44	+0.97%
Apple
BTC.X	106140.600000	110.890625	+0.10%
Bitcoin cryptocurrency
SPY	604.29	-2.50	-0.41%
SPDR® S&P 500® ETF Trust

EQ and Stocks

Correlation & Price change

A.I.dvisor tells us that EQ and MTNB have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EQ and MTNB's prices will move in lockstep.

Ticker / NAME	Correlation To EQ	1D Price Change %
EQ	100%	+3.13%
MTNB - EQ	33% Poorly correlated	+10.16%
IMNM - EQ	32% Poorly correlated	-3.38%
AUTL - EQ	29% Poorly correlated	-3.49%
ATAI - EQ	24% Poorly correlated	-0.75%
ATXS - EQ	24% Poorly correlated	-1.24%
More